When Diagnostics Must Keep Evolving: Frank Basile on AI, Toxicology and Leadership at Aegis Sciences

Key Takeaways

When Better Diagnostics Can Change the Course of Care

“The value of the information that you receive really can bend the nature of the course of treatment for a patient.”

Basile’s journey began as a physician in Australia before taking him to McKinsey, dialysis organizations including what became DaVita, and ultimately diagnostic medicine. What drew him deeper into diagnostics was the extraordinary influence information can have on clinical decision-making.

For Basile, diagnostics is not simply about producing a laboratory result. It is about giving clinicians better information at the moment they need to make consequential decisions.

Innovation Means Keeping Pace With What Is Changing

“Not all toxicology tests are equal.”

Toxicology presents an unusual innovation challenge because the substances laboratories need to detect are continually evolving. Aegis monitors government reports, forensic research, local reporting, customer feedback, and its own testing data to determine which analytes should be added or removed from its testing methods.

Every six months, the company may identify roughly 30 to 35 substances that need to be added while removing others that have disappeared from the drug supply.

Where Chemistry, Physics, Software and Data Meet

“Chemistry, physics, as well as software engineering, all of which combine to create the result.”

Modern toxicology is far more than laboratory chemistry. Basile describes a highly integrated process involving liquid chromatography, tandem mass spectrometry, molecular analysis, software engineering, and substantial data processing.

Aegis frequently tests for hundreds of analytes simultaneously. The resulting complexity is managed partly through software developed internally to capture, interpret, and convert large volumes of laboratory data into information humans can use.

AI With a Business Case, Not AI for the Sake of AI

“It has to have business value, it has to improve quality, it has to be compliant.”

Aegis is already applying AI and machine learning in areas where Basile sees measurable operational value. That includes identifying trends and outliers in laboratory data, predicting maintenance needs across nearly 100 mass spectrometers, and analyzing RFID-generated workflow data to uncover bottlenecks and remove non-value-added time.

Basile is equally clear that not every process needs to be automated immediately. He believes there are substantial opportunities to improve processes around laboratory operations before using AI to replace certain forms of human interpretation.

The Biggest Opportunities Often Live Between the Silos

“It’s the gaps in between where the value is.”

Basile’s leadership philosophy extends beyond technology. While functional leaders may be effective at optimizing their individual departments, he believes significant value is often created through collaboration across organizational boundaries.

By creating forums where clinical, R&D, laboratory, sales, and other teams can exchange information, Aegis can move customer observations more quickly into research, development, and ultimately new solutions.

That philosophy also shapes Basile’s advice for emerging scientists, engineers, doctors, and innovators.

Listen on your Favorite Platform